Full Coverage

Xoft systems gets FDA clearance for use in endometrial cancer

bizjournals.com
May 21, 2008
        
Story Timeline:  197 days

Silicon Valley / San Jose Business Journal said Wednesday it received clearance from the U.S. Food & Drug Administration for applicators to be used with an electronic brachytherapy system for the treatment of endometrial cancer. Sunnyvale-based Xoft said its system was previously cleared for... [read full story]                    

Add Comment
Latest article on this story:

FDA Clears New Applicators for Endometrial Cancer Treatment With Xoft Inc.'s Axxent(R) Electronic...

 biospace.com May 21, 2008
First article on this story:

FDA Clears New Applicators for Endometrial Cancer Treatment With FDA's Axxent(R) Electronic...

 biospace.com May 21, 2008
Selected publications with coverage of this story:
biospace.com bizjournals.com
RELATED
Found 2 documents:
                   

FDA Clears New Applicators for Endometrial Cancer Treatment With Xoft Inc.'s Axxent(R) Electronic...

biospace.com
May 21, 2008
        

SUNNYVALE, Calif., May 21 /PRNewswire/ -- Xoft, Inc., today announced that it has received clearance from the U.S. Food & Drug Administration (FDA) for applicators to be used with the Axxent Electronic Brachytherapy System for the treatment of endometrial cancer. Previously cleared for...

                   

FDA Clears New Applicators for Endometrial Cancer Treatment With FDA's Axxent(R) Electronic...

biospace.com
May 21, 2008
        

SUNNYVALE, Calif., May 21 /PRNewswire/ -- Xoft, Inc., today announced that it has received clearance from the U.S. Food & Drug Administration (FDA) for applicators to be used with the Axxent Electronic Brachytherapy System for the treatment of endometrial cancer. Previously cleared for...